应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EWTX Edgewise Therapeutics, Inc.
已收盘 09-27 16:00:00 EDT
26.09
+0.10
+0.38%
盘后
26.09
+0.00
0.00%
19:30 EDT
最高
26.91
最低
25.65
成交量
76.90万
今开
26.01
昨收
25.99
日振幅
4.85%
总市值
24.47亿
流通市值
13.75亿
总股本
9,377万
成交额
2,010万
换手率
1.46%
流通股本
5,270万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Edgewise Therapeutics, Inc.盘中异动 快速下跌5.02%报25.16美元
市场透视 · 09-25
Edgewise Therapeutics, Inc.盘中异动 快速下跌5.02%报25.16美元
美国研究综述-Factset、联邦快递、赛默飞世尔科技公司
Reuters · 09-20
美国研究综述-Factset、联邦快递、赛默飞世尔科技公司
BUZZ--美国股票走势-Spotify、Coursera、Tandem 糖尿病护理公司
Reuters · 09-20
BUZZ--美国股票走势-Spotify、Coursera、Tandem 糖尿病护理公司
BUZZ-Edgewise Therapeutics 因心脏病药物的早期数据而跃升
Reuters · 09-19
BUZZ-Edgewise Therapeutics 因心脏病药物的早期数据而跃升
Edgewise Therapeutics, Inc.盘中异动 早盘大幅上涨35.03%报25.75美元
市场透视 · 09-19
Edgewise Therapeutics, Inc.盘中异动 早盘大幅上涨35.03%报25.75美元
Edgewise Therapeutics, Inc.盘中异动 大幅拉升5.13%报19.79美元
自选股智能写手 · 08-21
Edgewise Therapeutics, Inc.盘中异动 大幅拉升5.13%报19.79美元
异动解读 | Edgewise Therapeutics盘中大涨7.45% 机构看好前景
异动解读 · 08-16
异动解读 | Edgewise Therapeutics盘中大涨7.45% 机构看好前景
Edgewise Therapeutics, Inc.2024财年第二财季实现净利润-31.50百万美元,同比减少46.72%
自选股智能写手 · 08-16
Edgewise Therapeutics, Inc.2024财年第二财季实现净利润-31.50百万美元,同比减少46.72%
Edgewise Therapeutics, Inc.盘中异动 急速拉升5.28%
自选股智能写手 · 08-15
Edgewise Therapeutics, Inc.盘中异动 急速拉升5.28%
美国研究综述-Airbnb、通用美元、沃尔玛
Reuters · 08-12
美国研究综述-Airbnb、通用美元、沃尔玛
Edgewise Therapeutics Inc 预计每股亏损 34 美分 - 财报前瞻
Reuters · 08-07
Edgewise Therapeutics Inc 预计每股亏损 34 美分 - 财报前瞻
Edgewise Therapeutics, Inc.盘中异动 股价大涨5.05%报19.68美元
自选股智能写手 · 07-26
Edgewise Therapeutics, Inc.盘中异动 股价大涨5.05%报19.68美元
成分股MeiraGTx收涨11.62%,AC Immune涨10.76%,诺瓦瓦克斯医药涨8.25%表现第三,和黄医药则收跌3.
华尔街见闻 · 07-26
成分股MeiraGTx收涨11.62%,AC Immune涨10.76%,诺瓦瓦克斯医药涨8.25%表现第三,和黄医药则收跌3.
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
华尔街见闻 · 07-11
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
华尔街见闻 · 07-11
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
加拿大皇家银行:重申Edgewise Therapeutics(EWTX.US)评级,由优于大市调整至优于大市评级, 目标价由32.
智通财经 · 07-10
加拿大皇家银行:重申Edgewise Therapeutics(EWTX.US)评级,由优于大市调整至优于大市评级, 目标价由32.
小摩:维持Edgewise Therapeutics(EWTX.US)评级,由增持调整至增持评级, 目标价由27.00美元调整至30.
智通财经 · 07-09
小摩:维持Edgewise Therapeutics(EWTX.US)评级,由增持调整至增持评级, 目标价由27.00美元调整至30.
Edgewise Therapeutics, Inc.盘中异动 早盘急速拉升5.02%报21.97美元
自选股智能写手 · 07-09
Edgewise Therapeutics, Inc.盘中异动 早盘急速拉升5.02%报21.97美元
美国研究综述-Alphabet、多米诺比萨、McKesson
Reuters · 07-09
美国研究综述-Alphabet、多米诺比萨、McKesson
Edgewise Therapeutics, Inc.盘中异动 股价大跌5.00%
自选股智能写手 · 07-03
Edgewise Therapeutics, Inc.盘中异动 股价大跌5.00%
加载更多
公司概况
公司名称:
Edgewise Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Edgewise Therapeutics, Inc.于2017年5月成立为特拉华州公司,总部位于科罗拉多州博尔德。 该公司是一家临床阶段的生物制药公司,致力于发现,开发和商业化针对严重,罕见的肌肉疾病的新疗法,这些药物对于医疗的需求尚未得到充分满足。公司的主要候选产品EDG-5506是一种口服小分子药物,旨在解决营养不良症的根本原因,包括杜氏肌营养不良(DMD)和贝克尔肌营养不良(BMD)。针对主要肌肉蛋白质和调节剂的精密药物候选产品的渠道,以解决广泛的遗传定义的肌肉疾病。
发行价格:
--
{"stockData":{"symbol":"EWTX","market":"US","secType":"STK","nameCN":"Edgewise Therapeutics, Inc.","latestPrice":26.09,"timestamp":1727467200000,"preClose":25.99,"halted":0,"volume":769039,"hourTrading":{"tag":"盘后","latestPrice":26.09,"preClose":26.09,"latestTime":"19:30 EDT","volume":9873,"amount":257586.7188,"timestamp":1727479836750},"delay":0,"floatShares":52699791,"shares":93772288,"eps":-1.498438,"marketStatus":"已收盘","marketStatusCode":5,"change":0.1,"latestTime":"09-27 16:00:00 EDT","open":26.01,"high":26.91,"low":25.65,"amount":20099800.947023,"amplitude":0.04848,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.498438,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1727683200000},"adr":0,"listingDate":1616731200000,"adjPreClose":25.99,"preHourTrading":{"tag":"盘前","latestPrice":26,"preClose":25.99,"latestTime":"08:32 EDT","volume":40,"amount":1049.2212,"timestamp":1727440360274},"postHourTrading":{"tag":"盘后","latestPrice":26.09,"preClose":26.09,"latestTime":"19:30 EDT","volume":9873,"amount":257586.7188,"timestamp":1727479836750},"volumeRatio":0.431718,"impliedVol":0.7395,"impliedVolPercentile":0.2937},"requestUrl":"/m/hq/s/EWTX","defaultTab":"news","newsList":[{"id":"2470448272","title":"Edgewise Therapeutics, Inc.盘中异动 快速下跌5.02%报25.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470448272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470448272?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:12","pubTimestamp":1727201539,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时12分,Edgewise Therapeutics, Inc.股票出现波动,股价急速下挫5.02%。截至发稿,该股报25.16美元/股,成交量42.8638万股,换手率0.46%,振幅5.83%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.01%。其相关个股中,Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃,换手率分别为4528.64%、198.00%、176.35%,振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.,振幅分别为122.95%、58.52%、45.08%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502121998e38b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502121998e38b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","EWTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2468917646","title":"美国研究综述-Factset、联邦快递、赛默飞世尔科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468917646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468917646?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:20","pubTimestamp":1726816830,"startTime":"0","endTime":"0","summary":" 路透9月20日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Factset、联邦快递和赛默飞世尔科技。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPC","FDS","AEP","EXC","IE0009355771.USD","IDA","D","LU2210149790.SGD","IE00BMG7P702.HKD","DINO","AEE","DNA","EWTX","PSX","LU0957791311.USD","LU2063271972.USD","PNW","PARR","DRI","IE00BVYPNV92.GBP","LU1854103824.USD","GIS","BK4519","DK","FDX","LNT","BK4504","IQV","EVRG","ENVA","AJG","OGE","CRL","PBF","IE00B19Z8X17.USD","ALL","LU0342679015.USD","TMO","ASMB","GLW","LU1670628061.USD","MEDP","IE00B3T34201.USD","LU2210150020.SGD","LU2095319765.USD","LU2065170008.USD","LH","LU0114720955.EUR","DUK","PSTL"],"gpt_icon":1},{"id":"2468042765","title":"BUZZ--美国股票走势-Spotify、Coursera、Tandem 糖尿病护理公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468042765","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468042765?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:05","pubTimestamp":1726761931,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月19日 - 在美联储以削减半个百分点开启宽松周期并预测将有更多削减后,华尔街周四反弹,标普500指数再创盘中纪录新高。美东时间11:34,道琼斯工业平均指数 上涨1.02%,报41,927.77点。标普500指数 上涨1.66%,报5711.6点;纳斯达克综合指数 上涨2.66%,报18040.538点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXD","HESM","VNDA","TGT","VST","DRI","LEN","LU","COUR","SQQQ","MBLY","DOG","NQmain","CRMT","FITB","KBH","2NVD.UK","ELAN","FDS",".IXIC","AHR","IEF","CRK","TQQQ","UDOW","EWTX","TOL",".DJI","3NVD.UK","DASH","DJX","TNDM","SPOT","BANC","DHI","PHM","ANGL","KEY"],"gpt_icon":1},{"id":"2468506319","title":"BUZZ-Edgewise Therapeutics 因心脏病药物的早期数据而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2468506319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468506319?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:59","pubTimestamp":1726757964,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 9月19日 - ** 药物开发商Edgewise Therapeutics 股价飙升45%,创下27.66美元的逾3年新高 ** 该公司称其治疗心脏病的实验性药物在一项早期研究中耐受性良好 ** EDG-7500 是一种用于治疗阻塞性肥厚型心肌病的药物,这种疾病会导致心肌增厚,增加心脏泵血的难度。 ** Truist Securities 分析师认为:\"早期数据表明,该药物正在发挥预期作用。 ** Truist将EWTX的PT值从25美元上调至33美元,较上一交易日收盘价上涨73%。** 包括盘中涨幅在内,该股今年累计涨幅超过一倍","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","EWTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2468076572","title":"Edgewise Therapeutics, Inc.盘中异动 早盘大幅上涨35.03%报25.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468076572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468076572?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:30","pubTimestamp":1726752605,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时30分,Edgewise Therapeutics, Inc.股票出现异动,股价快速上涨35.03%。截至发稿,该股报25.75美元/股,成交量184.455万股,换手率1.97%,振幅0.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,Edgewise Therapeutics, Inc.、Seres Therapeutics, Inc.、Candel Therapeutics, Inc.涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃,换手率分别为991.18%、299.68%、66.56%,振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.,振幅分别为0.00%、0.00%、0.00%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213006a1db30ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213006a1db30ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","EWTX","BK4139"],"gpt_icon":0},{"id":"2461188796","title":"Edgewise Therapeutics, Inc.盘中异动 大幅拉升5.13%报19.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461188796","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461188796?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:39","pubTimestamp":1724175546,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时39分,Edgewise Therapeutics, Inc.股票出现异动,股价快速拉升5.13%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Inmed Pharmaceuticals Inc.、泰坦制药、Cingulate Inc.较为活跃,换手率分别为3522.94%、2468.06%、799.17%,振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Biomotion Sciences C/Wts Exp 15/08/2029 ,振幅分别为274.86%、128.68%、78.89%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082101390698e35938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082101390698e35938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","EWTX","LENZ"],"gpt_icon":0},{"id":"1183248636","title":"异动解读 | Edgewise Therapeutics盘中大涨7.45% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1183248636","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183248636?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:30","pubTimestamp":1723739425,"startTime":"0","endTime":"0","summary":"北京时间2024年8月15日,生物制药公司Edgewise Therapeutics, Inc.股价在盘中出现大涨,最高上涨7.45%,报收17.95美元/股。公开消息显示,EWTX股价在当日盘中一度急速拉升5.28%,引发市场关注。分析人士认为,这可能与机构对该公司前景看好有关。Edgewise Therapeutics是一家临床阶段的生物制药公司,专注于开发治疗严重罕见肌肉疾病的创新疗法。公司正在研发口服小分子药物治疗肌肉骨骼疾病,在这一领域具有较强的竞争力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX"],"gpt_icon":0},{"id":"2459223477","title":"Edgewise Therapeutics, Inc.2024财年第二财季实现净利润-31.50百万美元,同比减少46.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459223477","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459223477?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737809,"startTime":"0","endTime":"0","summary":"8月16日,Edgewise Therapeutics, Inc.公布财报,公告显示公司2024财年第二财季净利润为-31.50百万美元,同比减少46.72%;其中营业收入为0.00美元,每股基本收益为-0.34美元。从资产负债表来看,Edgewise Therapeutics, Inc.总负债21.17百万美元,其中短期债务988000.00美元,资产负债比为0.26,流动比率为0.31。机构评级:截至2024年8月16日,当前有6家机构对Edgewise Therapeutics, Inc.目标价做出预测,其中目标均价为33.17美元,其中最低目标价为25.00美元,最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2459420495","title":"Edgewise Therapeutics, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420495?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728667,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分,Edgewise Therapeutics, Inc.股票出现异动,股价急速拉升5.28%。截至发稿,该股报17.95美元/股,成交量9182股,换手率0.01%,振幅1.58%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为2303.07%、1455.32%、333.77%,振幅较大的相关个股有Cingulate Inc.、Celcuity Inc.、Absci Corporation,振幅分别为28.18%、9.31%、9.11%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","EWTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2458749620","title":"美国研究综述-Airbnb、通用美元、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2458749620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458749620?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:40","pubTimestamp":1723448430,"startTime":"0","endTime":"0","summary":" 路透8月12日 - 华尔街证券分析师周一调整了对多家美国上市公司的评级和目标价,其中包括 Airbnb、Dollar General 和沃尔玛。要闻 * Airbnb Inc :杰富瑞将目标价从 150 美元下调至 125 美元 * Dollar General Corp :杰富瑞将目标价从160美元下调至145美元 * Hilton Grand Vacations Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Pacira Biosciences Inc :摩根大通将目标价从45美元下调至10美元 * Pacira Biosciences Inc :Piper Sandler将目标价从42美元下调至11美元 * Pacira Biosciences Inc :Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069347547.HKD","ARDT","WMT","DG","BURL","SWIM","BJ","BTAI","LU1066051225.USD","LEGH","NNI","BK4175","CCOI","CBUS","BK4535","OPAD","BK4173","HGV","SKY","EXPE","RDFN","FTDR","HBI","PCRX","LU2361045086.USD","GSHD","DLTR","HSIC","GCMG","CARG","LU2361044865.SGD","FMC","IE0034390439.USD","PX","EWTX","ZD","STEP","GHLD","RDNT","ITOS","ABNB","CC","BWIN","NTLA","ROK","OKE","LU2361044949.HKD","HLMN","LU0211327993.USD"],"gpt_icon":1},{"id":"2457077846","title":"Edgewise Therapeutics Inc 预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077846","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077846?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:32","pubTimestamp":1722969162,"startTime":"0","endTime":"0","summary":" * Edgewise Therapeutics Inc 预计在8月8日公布截至0001年1月1日的业绩时,季度收入将没有变化(预计)。* * LSEG分析师对Edgewise Therapeutics Inc的平均预期是每股亏损34美分。* 华尔街对 Edgewise Therapeutics Inc 的 12 个月目标价中位数为 32.00 美元,高于其上次收盘价 15.89 美元。8月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2454328342","title":"Edgewise Therapeutics, Inc.盘中异动 股价大涨5.05%报19.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328342","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328342?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:44","pubTimestamp":1722001474,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时44分,Edgewise Therapeutics, Inc.股票出现异动,股价急速拉升5.05%。截至发稿,该股报19.68美元/股,成交量5.1848万股,换手率0.06%,振幅4.54%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大,Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃,换手率分别为3555.08%、114.52%、57.42%,振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为56.23%、49.58%、26.50%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214435af945996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214435af945996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","EWTX","LENZ"],"gpt_icon":0},{"id":"2454382913","title":"成分股MeiraGTx收涨11.62%,AC Immune涨10.76%,诺瓦瓦克斯医药涨8.25%表现第三,和黄医药则收跌3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382913","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454382913?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:45","pubTimestamp":1721940358,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4135","HCM","BK4531","AC","NVAX","BK1587","BK4588","BK4585","BK1588","BK4568","BK4539","EWTX","BK4547","BK4007","JANX","00013","BK1191","BK4139","LENZ"],"gpt_icon":0},{"id":"2450824715","title":"成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824715","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824715?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:37","pubTimestamp":1720651031,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["LENZ","ZNTL","KYMR","BK4007","FULC","BK4539","EWTX","AMRN","OCUL","BK4139"],"gpt_icon":0},{"id":"2450824369","title":"成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824369","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824369?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:00","pubTimestamp":1720648815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["KYMR","OCUL","BK4007","EWTX","AMRN","BK4139","FULC","ZNTL","LENZ","BK4539"],"gpt_icon":0},{"id":"2450975818","title":"加拿大皇家银行:重申Edgewise Therapeutics(EWTX.US)评级,由优于大市调整至优于大市评级, 目标价由32.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450975818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450975818?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:31","pubTimestamp":1720618265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","EWTX","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2450021741","title":"小摩:维持Edgewise Therapeutics(EWTX.US)评级,由增持调整至增持评级, 目标价由27.00美元调整至30.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450021741","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450021741?lang=zh_cn&edition=full","pubTime":"2024-07-09 23:04","pubTimestamp":1720537440,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0310799852.SGD","LU2552382058.USD","BK4581","LU0211331839.USD","LU1363072403.SGD","LU0149725797.USD","LU0211326755.USD","LU2552382215.SGD","LU0238689110.USD","LU0070302665.USD","LU0211328371.USD","IE00BZ1G4Q59.USD","IE00BJTD4V19.USD","LU1032466523.USD","LU1496350502.SGD","LU0211327993.USD","LU0211326839.USD","LU2552382132.HKD","IE00BLSP4239.USD","BK4588","LU1668664300.SGD","IE00B775SV38.USD","BK4566","EWTX","IE0034235188.USD","LU0882574139.USD","IE00BJTD4N35.SGD","BK4550","LU0496365809.HKD","LU2106854487.HKD","LU0208291251.USD","BK4539","LU1244550221.USD","BK4007","LU1244550577.SGD","LU0971096721.USD","LU1162221912.USD","LU0256863811.USD","IE00BKVL7J92.USD","LU1496350171.SGD","LU2023250504.SGD","IE00BLSP4452.SGD","LU1670628061.USD","LU0234572021.USD","BK4504","BK4207","IE00BWXC8680.SGD","LU1917777945.USD","LU0417517546.SGD","LENZ"],"gpt_icon":0},{"id":"2450015021","title":"Edgewise Therapeutics, Inc.盘中异动 早盘急速拉升5.02%报21.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450015021","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450015021?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:51","pubTimestamp":1720536700,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时51分,Edgewise Therapeutics, Inc.股票出现波动,股价急速上涨5.02%。截至发稿,该股报21.97美元/股,成交量14.6011万股,换手率0.16%,振幅5.14%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Soligenix, Inc.、Uniqure N.V.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Soligenix, Inc.、Longeveron Inc.、Anew Medical, Inc.较为活跃,换手率分别为7771.51%、231.54%、133.15%,振幅较大的相关个股有Soligenix, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Longeveron Inc.,振幅分别为317.50%、76.52%、50.19%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225140941f574d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225140941f574d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","EWTX","LENZ"],"gpt_icon":0},{"id":"2450060385","title":"美国研究综述-Alphabet、多米诺比萨、McKesson","url":"https://stock-news.laohu8.com/highlight/detail?id=2450060385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450060385?lang=zh_cn&edition=full","pubTime":"2024-07-09 14:49","pubTimestamp":1720507794,"startTime":"0","endTime":"0","summary":" 路透7月9日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Alphabet、Domino's Pizza 和 McKesson。要闻 * Alphabet Inc :杰富瑞将目标价从215美元上调至220美元 * Domino's Pizza Inc :贝尔德上调其评级至 \"跑赢大盘\",目标价从530美元上调至580美元 * McKesson Corp :贝雅将目标价从679美元上调至694美元 * Teleflex Inc :Truist Securities将目标价从219美元上调至235美元 * Tradeweb Markets Inc :Raymond James将目标价从115美元上调至117美元 以下是路透周二报道的美国公司研究报告摘要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800965.SGD","BK4585","LU0006061336.USD","BK4023","TEM","LU2087625088.SGD","DPZ","LU2065169927.USD","IE00BJTD4V19.USD","MCK","LU0310800379.SGD","CRNX","CMG","CGC","EWTX","LU0320765059.SGD","LU0149725797.USD","DIN","CAH","BK4112","BK4588","BK4579","LU0494093205.USD","LU0889566641.SGD","LU1983260115.SGD","SG9999004303.SGD","BK4503","BK4576","LU0170899867.USD","TFX","ACM","GOOGL","ZETA","SIMO","SGXZ81514606.USD","LU0211328371.USD","LU0742534661.SGD","KYMR","COR","LU1267930730.SGD","LU2125154778.USD","DVN","EPR","LU1430594728.SGD","LU0048573561.USD","DYN","IE00BKVL7J92.USD","LU0127658192.USD","BK4141","TW"],"gpt_icon":0},{"id":"2448169066","title":"Edgewise Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448169066","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448169066?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:10","pubTimestamp":1719936602,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时10分,Edgewise Therapeutics, Inc.股票出现异动,股价快速跳水5.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Zura Bio Limited C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Annovis Bio, Inc.涨幅较大,Mustang Bio, Inc.、Gri Bio, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为56.42%、49.80%、40.83%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Annovis Bio, Inc.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为72.83%、43.24%、39.76%。Edgewise Therapeutics, Inc.公司简介:Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703001003af90373d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703001003af90373d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","EWTX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgewisetx.com","stockEarnings":[{"period":"1week","weight":-0.119},{"period":"1month","weight":0.314},{"period":"3month","weight":0.4431},{"period":"6month","weight":0.4249},{"period":"1year","weight":3.2607},{"period":"ytd","weight":1.3757}],"compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0516},{"period":"6month","weight":0.0941},{"period":"1year","weight":0.3433},{"period":"ytd","weight":0.2041}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Edgewise Therapeutics, Inc.于2017年5月成立为特拉华州公司,总部位于科罗拉多州博尔德。 该公司是一家临床阶段的生物制药公司,致力于发现,开发和商业化针对严重,罕见的肌肉疾病的新疗法,这些药物对于医疗的需求尚未得到充分满足。公司的主要候选产品EDG-5506是一种口服小分子药物,旨在解决营养不良症的根本原因,包括杜氏肌营养不良(DMD)和贝克尔肌营养不良(BMD)。针对主要肌肉蛋白质和调节剂的精密药物候选产品的渠道,以解决广泛的遗传定义的肌肉疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.221382},{"month":2,"riseRate":0,"avgChangeRate":-0.093585},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.121355},{"month":4,"riseRate":0.25,"avgChangeRate":0.000577},{"month":5,"riseRate":0.5,"avgChangeRate":-0.024995},{"month":6,"riseRate":0.5,"avgChangeRate":-0.042597},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019509},{"month":8,"riseRate":0.5,"avgChangeRate":-0.023659},{"month":9,"riseRate":0.5,"avgChangeRate":0.081776},{"month":10,"riseRate":0.333333,"avgChangeRate":0.025789},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.017709},{"month":12,"riseRate":0.333333,"avgChangeRate":0.225126}],"exchange":"NASDAQ","name":"Edgewise Therapeutics, Inc.","nameEN":"Edgewise Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Edgewise Therapeutics, Inc.,EWTX,Edgewise Therapeutics, Inc.股票,Edgewise Therapeutics, Inc.股票老虎,Edgewise Therapeutics, Inc.股票老虎国际,Edgewise Therapeutics, Inc.行情,Edgewise Therapeutics, Inc.股票行情,Edgewise Therapeutics, Inc.股价,Edgewise Therapeutics, Inc.股市,Edgewise Therapeutics, Inc.股票价格,Edgewise Therapeutics, Inc.股票交易,Edgewise Therapeutics, Inc.股票购买,Edgewise Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}